BRIEF-CSPC Pharmaceutical Expects Decrease In Profit Attributable For Year Of 26%

Reuters
25 Feb
BRIEF-CSPC Pharmaceutical Expects Decrease In Profit Attributable For Year Of 26%

Feb 25 (Reuters) - CSPC Pharmaceutical Group Ltd 1093.HK:

  • SEES DECREASE IN PROFIT ATTRIBUTABLE FOR YEAR OF 26%

  • EXPECTED RESULT DUE TO DECREASE IN REVENUE OF FINISHED DRUGS BUSINESS FOR YEAR

Further company coverage: 1093.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10